Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model

Cancer Letters

Volumn 192, Issue 2, 2003, Pages 133-143

  Hewitt, Amy L ^a   Singletary, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Mammary adenocarcinoma; p21waf1 cip1; Soy

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GENISTEIN; PLANT EXTRACT; PROGESTERONE RECEPTOR; PROTEIN P21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOYBEAN;

ANIMALIA; GLYCINE MAX;

EID: 0037474707     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00712-7     Document Type: Article

References (47)

1. Breast Cancer Resource Center. American Cancer Society, Inc. http://www3.cancer.org/cancerinfo/load_cont.asp?ct=5&language=English (Accessed April 29, 2001).
2. Willett W. The search for the causes of breast and colon cancer. Nature. 338:1989;389-394.
3. Shimizu H., Ross R.K., Bernstein L., Yatani R., Henderson B.E., Mack T.M. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles Country. Br. J. Cancer. 63:1991;963-966.
4. Wu A.H., Ziegler R.G., Horn-Ross P.L., Nomura A.M., West D.W., Kolonel L.N., Rosenthal J.F., Hoover R.N., Pike M.C. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol. Biomarkers Prev. 5:1996;901-906.
5. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects on breast-cancer risk in Singapore. Lancet. 337:1991;1197-1200.
6. Dai Q., Shu X.O., Jin F., Potter J.D., Kushi L.H., Teas J., Gao Y.T., Zheng W. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer. 85:2001;372-378.
7. Shu X.O., Jin F., Dai Q., Wen W., Potter J.D., Kushi L.H., Ruan Z., Gao Y.T., Zheng W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 10:2001;483-488.
8. CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell Res. 258:2000;101-108.
9. 2M phase of the cell cycle. J. Cell. Biochem. 79:2000;594-600.
10. Elattar T.M.A., Virji A.S. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 20:2000;1733-1738.
11. Lin H.M., Moon B.K., Yu F., Kim H.R.C. Galectin-3 mediates genistein-induced G2/M arrest and inhibits apoptosis. Carcinogenesis. 21:2000;1941-1945.
12. Alhasan S.A., Pietrasczkiwicz H., Alonso M.D., Ensley J., Sarkar F.H. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr. Cancer. 34:1999;12-19.
13. Shen J.C., Klein R.D., Wei Q., Guan Y., Contois J.H., Wang T.T.Y., Chang S., Hursting S.D. Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells. Mol. Carcinog. 29:2000;92-102.
14. Upadhyay S., Neburi M., Chinni S.R., Alhasan S., Miller F., Sarkar F.H. Differential sensitivity of normal and malignant breast epithelial cells to genistein s partly mediated by p21(waf1). Clin. Cancer Res. 7:2001;1782-1789.
15. Lian F., Li Y., Bhuiyan M., Sarkar F.H. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr. Cancer. 33:1999;125-131.
16. Upadhyaya P., El-Bayoumy K. Effect of dietary soy protein isolate, genistein, and 1,4-phenylenebis(methylene)selenocyanate on DNA binding of 7,12-dimethylbenz[a]anthracene in mammary glands of CD rats. Oncol. Rep. 5:1998;1541-1545.
17. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
18. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer. 30A:1994;1675-1682.
19. Spinozzi F., Pagliacci M.C., Migliorati G., Moraca R., Grignani F., Riccardi C., Nicoletti I. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk. Res. 18:1994;431-439.
20. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J.M., Le Pecq J.B., Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:1989;5111-5117.
21. Constantinou A.I., Kiguchi K., Huberman E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50:1990;2618-2624.
22. Wang T.T.Y., Sathyamoorthy N., Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 17:1996;271-275.
23. Constantinou A.I., Mehta R.G., Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 16:1996;3293-3298.
24. Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res. Treat. 46:1997;169-179.
25. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58:1998;3833-3838.
26. Ju Y.H., Allred C.D., Allred K.F., Karko K.L., Doerge D.R., Helferich W.G. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131:2001;2957-2962.
27. Shao Z., Wu J., Shen Z.Z., Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58:1998;4851-4857.
28. Allred C.D., Ju Y.H., Allred K.F., Chang J., Helferich W.G. Dietary genistein stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis. 22:2001;1667-1673.
29. Alonso D.F., Farias E.F., Urtreger A., Ladeda V., Vidal M.C., Bal De Kier Joffe E. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma. J. Surg. Oncol. 62:1996;288-297.
30. Alonso D.F., Farina H.G., Skilton G., Gabri M.R., De Lorenzo M.S., Gomez D.E. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Breast Cancer Res. Treat. 50:1998;83-93.
31. Menon L.G., Kuttan R., Nair M.G., Chang Y.C., Kuttan G. Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr. Cancer. 30:1998;74-77.
32. Li D., Yee J.A., McGuire M.H., Murphy P.A., Yan L. Soybean isoflavones reduce experimental metastasis in mice. J. Nutr. 129:1999;1075-1078.
33. Denton C.P. Leucine incorporation and thymidine incorporation. Morgan D.M. Polyamine Protocols. 1998;169-177 Humana Press, Totowa, NJ.
34. Santell R.C., Kieu N., Helferich W.G. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J. Nutr. 130:2000;1665-1669.
35. Connolly J.M., Liu X.H., Rose D.P. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. Nutr. Cancer. 29:1997;48-54.
36. Choi Y.H., Zhang L., Lee W.H., Park K.Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol. 13:1998;391-396.
37. Constantinou A.I., Kamath N., Murley J.S. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer. 34:1998;1927-1934.
38. Choi Y.H., Lee W.H., Park K.Y., Zhang L. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91:2000;164-173.
39. Nakagawa H., Yamamoto D.Y., Kiyozuka Y., Tsuta K., Uemura Y., Hioki K., Tsutsui Y., Tsubura A. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. J. Cancer Res. Clin. Oncol. 126:2000;448-454.
40. Peterson G., Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 7:1996;1345-1351.
41. Xu X., Wang H.J., Murphy P.A., Cook L., Hendrich S. Daidzein is a more available soy milk isoflavone than is genistein in adult women. J. Nutr. 124:1994;825-832.
42. Xu X., Harris K.S., Wang H.J., Murphy P.A., Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 25:1995;2307-2315.
43. Gautier J., Solomon M.J., Booher R.N., Bazan J.F., Kirsehner M.W. cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell. 67:1991;197-211.
44. Flatt P.M., Pietenpol J.A. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery. Drug Metab. Rev. 32:2000;283-305.
45. Frey R.S., Li J., Singletary K.W. Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem. Pharmacol. 61:2001;979-989.
46. Lian F., Bhuiyan M., Li Y.W., Wall N., Kraut M., Sarkar F.H. Genistein-induced G2-M arrest, p21(waf1) upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr. Cancer. 31:1998;184-191.
47. Mahungu S., Diaz-Mercado S., Schwenk J., Singletary K., Faller J. Stability of isoflavones during extrusion processing of corn/soy mixture. J. Agric. Food Chem. 47:1999;279-284.